Chloroquine to treat ongoing atrial fibrillation symptoms
Part of Heart & circulation clinical trials.
This trial tests whether chloroquine can reduce symptoms in people with persistent atrial fibrillation (AF), an irregular heartbeat that lasts longer than a week. It will also closely monitor heart rhythm and safety, since the medicine can affect the heart and other organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have persistent atrial fibrillation (it lasts more than 7 days but under 12 months), and it was documented in the past 24 months
- You are currently taking a blood thinner to help prevent stroke
- You have a pacemaker/ICD that can track AF, or you can wear a heart monitor for 2 weeks
- You can safely take chloroquine (no allergy, and your ECG is not showing a dangerous QTc prolongation)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This trial tests a step-by-step treatment plan for people with persistent atrial fibrillation (a type of irregular heartbeat) who live in Southwest China. The goal is to find a better way to manage and possibly fix this heart condition.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This trial looks at ways to help people with atrial fibrillation lower their risk of stroke, premature death, and worsening memory. It may help by identifying which prevention approach works best for a broader community of patients.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This study tests a new drug called BAY 3670549 to see if it can help convert atrial fibrillation (an irregular heartbeat) back to normal rhythm. You'll receive the study drug or a placebo along with a procedure to restore your heart's normal rhythm, and researchers will monitor how well it works and how safe it is.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.